CuraSen Therapeutics

Rethinking Brain Disease

United States · $60.3M raised

Business Model
B2B
Total Funding
$60.3M
Last Round
$5.8M GrantOct 2023
Rounds
2

About

CuraSen Therapeutics is a privately funded biopharmaceutical company pursuing development of novel treatments for psychiatric and neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, PSP, and ALS. The company is rethinking prevailing therapeutic approaches by targeting the loss of noradrenergic signaling in the degenerating brain — specifically developing treatments that activate adrenergic receptors to restore cognitive function and brain health. CuraSen's lead program, CuraAX (CST-3056), is in Phase 1 clinical trials for neurogenic orthostatic hypotension in Parkinson's disease patients. The company is backed by investors including New Leaf Venture Partners, Longitude Capital, J&J Innovation, and the Alzheimer's Drug Discovery Foundation.

Summary

CuraSen Therapeutics is a Biotech company based in United States. It has raised $60.3M in total across 2 rounds, most recently a $5.8M Grant round in Oct 2023. Investors include Alzheimer's Drug Discovery Foundation, New Leaf Venture Partners and Alta Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantOct 2023
$5.8M

Sign up to see all 2 rounds

Series A through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CuraSen Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/curasen-therapeutics"><img src="https://indexed.vc/api/badge/company/curasen-therapeutics" alt="CuraSen Therapeutics on Indexed.vc" width="260" height="76" /></a>